Increased App Expression in a Mouse Model of Down's Syndrome Disrupts NGF Transport and Causes Cholinergic Neuron Degeneration

Degeneration of basal forebrain cholinergic neurons (BFCNs) contributes to cognitive dysfunction in Alzheimer's disease (AD) and Down's syndrome (DS). We used Ts65Dn and Ts1Cje mouse models of DS to show that the increased dose of the amyloid precursor protein gene, App, acts to markedly decrease NGF retrograde transport and cause degeneration of BFCNs. NGF transport was also decreased in mice expressing wild-type human APP or a familial AD-linked mutant APP; while significant, the decreases were less marked and there was no evident degeneration of BFCNs. Because of evidence suggesting that the NGF transport defect was intra-axonal, we explored within cholinergic axons the status of early endosomes (EEs). NGF-containing EEs were enlarged in Ts65Dn mice and their App content was increased. Our study thus provides evidence for a pathogenic mechanism for DS in which increased expression of App, in the context of trisomy, causes abnormal transport of NGF and cholinergic neurodegeneration.

[1]  C. Howe,et al.  Trafficking the NGF signal: implications for normal and degenerating neurons. , 2004, Progress in brain research.

[2]  M. Davisson,et al.  Segmental trisomy of murine chromosome 16: a new model system for studying Down syndrome. , 1990, Progress in clinical and biological research.

[3]  W. Mobley,et al.  Nerve Growth Factor Activates Persistent Rap1 Signaling in Endosomes , 2001, The Journal of Neuroscience.

[4]  Aravinda Chakravarti,et al.  DNA duplication associated with Charcot-Marie-Tooth disease type 1A , 1991, Cell.

[5]  A. Singleton,et al.  alpha-Synuclein locus triplication causes Parkinson's disease. , 2003, Science.

[6]  T. Golde,et al.  A novel gamma -secretase assay based on detection of the putative C-terminal fragment-gamma of amyloid beta protein precursor. , 2001, The Journal of biological chemistry.

[7]  P. Hof.  Comparative cytoarchitectonic atlas of the C57BL/6 and 129/Sv mouse brains , 2000 .

[8]  R. Malenka,et al.  Hippocampal Long-Term Potentiation Suppressed by Increased Inhibition in the Ts65Dn Mouse, a Genetic Model of Down Syndrome , 2004, The Journal of Neuroscience.

[9]  C. Epstein,et al.  Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[10]  E. Mufson,et al.  Neuropathology of Mice Carrying Mutant APPswe and/or PS1M146L Transgenes: Alterations in the p75NTR Cholinergic Basal Forebrain Septohippocampal Pathway , 2001, Experimental Neurology.

[11]  D. Ginty,et al.  Evidence in Support of Signaling Endosome-Based Retrograde Survival of Sympathetic Neurons , 2003, Neuron.

[12]  D. Ginty,et al.  Functions and mechanisms of retrograde neurotrophin signalling , 2005, Nature Reviews Neuroscience.

[13]  N. Lenn,et al.  TrkA expression in the CNS: evidence for the existence of several novel NGF-responsive CNS neurons , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[14]  R. Quirion,et al.  Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. , 2002, Progress in neurobiology.

[15]  William C Mobley,et al.  Signaling endosome hypothesis: A cellular mechanism for long distance communication. , 2004, Journal of neurobiology.

[16]  D. Price,et al.  Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice [corrected]. , 1993, Nature genetics.

[17]  D. Lindholm,et al.  Atrophy but not death of adult septal cholinergic neurons after ablation of target capacity to produce mRNAs for NGF, BDNF, and NT3 , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[18]  J. Gécz,et al.  Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. , 2005, American journal of human genetics.

[19]  P. Yates,et al.  Pathological evidence for neurotransmitter deficits in Down's syndrome of middle age. , 2008, Journal of mental deficiency research.

[20]  A. Patel,et al.  A low-affinity nerve growth factor receptor antibody is internalized and retrogradely transported selectively into cholinergic neurons of the rat basal forebrain , 1993, Neuroscience.

[21]  D. Selkoe.  Alzheimer's Disease Is a Synaptic Failure , 2002, Science.

[22]  S. Gandy,et al.  Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain. , 2000, Experimental gerontology.

[23]  L. Goldstein,et al.  Disruption of Axonal Transport and Neuronal Viability by Amyloid Precursor Protein Mutations in Drosophila , 2001, Neuron.

[24]  D. Holtzman,et al.  Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. Price,et al.  Introduction and expression of the 400 kilobase precursor amyloid protein gene in transgenic mice , 1993, Nature Genetics.

[26]  D. Sirinathsinghji,et al.  Mice Deficient for the Amyloid Precursor Protein Gene , 1996, Annals of the New York Academy of Sciences.

[27]  M. Wessendorf,et al.  Fluro-Gold: composition, and mechanism of uptake , 1991, Brain Research.

[28]  C. Disteche,et al.  Down syndrome phenotypes: the consequences of chromosomal imbalance. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[29]  D. Wilkin,et al.  Neuron , 2001, Brain Research.

[30]  D. Borchelt,et al.  APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1 , 2004, Neurobiology of Aging.

[31]  R. Loy,et al.  Localization and development of nerve growth factor-sensitive rat basal forebrain neurons and their afferent projections to hippocampus and neocortex , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[32]  R. Quirion,et al.  Alzheimer’s disease and the basal forebrain cholinergic system: relations to β-amyloid peptides, cognition, and treatment strategies , 2002, Progress in Neurobiology.

[33]  D. Price,et al.  Erratum: Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice (Nature Genetics (1993) 5 (22-30)) , 1993 .

[34]  D. Campion,et al.  APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy , 2006, Nature Genetics.

[35]  M. Sofroniew,et al.  Nerve growth factor signaling, neuroprotection, and neural repair. , 2001, Annual review of neuroscience.

[36]  H. Phillips,et al.  Disruption of a Single Allele of the Nerve Growth Factor Gene Results in Atrophy of Basal Forebrain Cholinergic Neurons and Memory Deficits , 1997 .

[37]  M. Farrer,et al.  Molecular mapping of alzheimer‐type dementia in Down's syndrome , 1998, Annals of neurology.

[38]  D. Price,et al.  Altered metabolism of familial Alzheimer's disease-linked amyloid precursor protein variants in yeast artificial chromosome transgenic mice. , 1997, Human molecular genetics.

[39]  J. Shioi,et al.  Evidence for intracellular cleavage of the Alzheimer's amyloid precursor in PC12 cells , 1992, Journal of neuroscience research.

[40]  S. Gandy,et al.  Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain. , 2000, Neurology.

[41]  D. Borchelt,et al.  Accelerated Amyloid Deposition in the Brains of Transgenic Mice Coexpressing Mutant Presenilin 1 and Amyloid Precursor Proteins , 1997, Neuron.

[42]  F. Gage,et al.  NGF receptor reexpression and NGF-mediated cholinergic neuronal hypertrophy in the damaged adult neostriatum , 1989, Neuron.

[43]  D. Price,et al.  Mutant genes in familial Alzheimer's disease and transgenic models. , 1998, Annual review of neuroscience.

[44]  L. Goldstein,et al.  Do Disorders of Movement Cause Movement Disorders and Dementia? , 2003, Neuron.

[45]  Ahmad Salehi,et al.  Failed retrograde transport of NGF in a mouse model of Down's syndrome: Reversal of cholinergic neurodegenerative phenotypes following NGF infusion , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[46]  N. Berardi,et al.  Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice , 2000 .

[47]  Allan I. Levey,et al.  Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo , 1996, Neuron.

[48]  M. Pericak-Vance,et al.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.

[49]  S. Lipton,et al.  Molecular pathways to neurodegeneration , 2004, Nature Medicine.

[50]  R. S. Williams,et al.  A prospective study of Alzheimer disease in Down syndrome. , 1989, Archives of neurology.

[51]  R. Ravid,et al.  Decreased neuronal activity in the nucleus basalis of Meynert in Alzheimer's disease as suggested by the size of the Golgi apparatus , 1994, Neuroscience.

[52]  J. Coyle,et al.  Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis , 1981, Annals of neurology.

[53]  Y. Sakaki,et al.  Structure and expression of the alternatively-spliced forms of mRNA for the mouse homolog of Alzheimer's disease amyloid beta protein precursor. , 1989, Biochemical and biophysical research communications.

[54]  D. Selkoe,et al.  Sequence of Deposition of Heterogeneous Amyloid β-Peptides and APO E in Down Syndrome: Implications for Initial Events in Amyloid Plaque Formation , 1996, Neurobiology of Disease.

[55]  Janel O. Johnson,et al.  α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.

[56]  W. Mobley,et al.  NGF Signaling in Sensory Neurons Evidence that Early Endosomes Carry NGF Retrograde Signals , 2003, Neuron.

[57]  S. Gandy,et al.  Ovariectomy and 17β-estradiol modulate the levels of Alzheimer’s amyloid β peptides in brain , 2000, Neurology.

[58]  E. Zackai,et al.  Additional copies of the proteolipid protein gene causing Pelizaeus-Merzbacher disease arise by separate integration into the X chromosome. , 2000, American journal of human genetics.

[59]  E. Masliah,et al.  Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer's Disease , 2005, Science.

[60]  T. Golde,et al.  A Novel γ-Secretase Assay Based on Detection of the Putative C-terminal Fragment-γ of Amyloid β Protein Precursor* , 2000, The Journal of Biological Chemistry.

[61]  W. Mobley,et al.  Traffic at the intersection of neurotrophic factor signaling and neurodegeneration , 2003, Trends in Neurosciences.

[62]  S. Younkin,et al.  Expression of β amyloid protein precursor mRNAs: Recognition of a novel alternatively spliced form and quantitation in alzheimer's disease using PCR , 1990, Neuron.

[63]  W. Hong,et al.  Endofin, an Endosomal FYVE Domain Protein* , 2001, The Journal of Biological Chemistry.

[64]  Katheleen Gardiner,et al.  Mouse models of Down syndrome: how useful can they be? Comparison of the gene content of human chromosome 21 with orthologous mouse genomic regions. , 2003, Gene.

[65]  R. Morris,et al.  Activation of nicotinic acetylcholine receptors patterns network activity in the rodent hippocampus , 1999, The Journal of physiology.

[66]  P. Greengard,et al.  Presenilin-1 Regulates Intracellular Trafficking and Cell Surface Delivery of β-Amyloid Precursor Protein* , 2003, The Journal of Biological Chemistry.

[67]  C. Epstein,et al.  App Gene Dosage Modulates Endosomal Abnormalities of Alzheimer's Disease in a Segmental Trisomy 16 Mouse Model of Down Syndrome , 2003, The Journal of Neuroscience.

[68]  L. Butcher,et al.  Absence of p75NTR Causes Increased Basal Forebrain Cholinergic Neuron Size, Choline Acetyltransferase Activity, and Target Innervation , 1997, The Journal of Neuroscience.

[69]  O. Isacson,et al.  Abnormal APP, cholinergic and cognitive function in Ts65Dn Down's model mice , 2005, Experimental Neurology.

[70]  A. Sorkin,et al.  Endocytosis of Functional Epidermal Growth Factor Receptor-Green Fluorescent Protein Chimera* , 1998, The Journal of Biological Chemistry.

[71]  M. Sofroniew,et al.  Reduced transport of [125I]nerve growth factor by cholinergic neurons and down-regulated trka expression in the medial septum of aged rats , 1994, Neuroscience.

[72]  T. Jovin,et al.  Ligand-Induced Internalization of the p75 Neurotrophin Receptor: A Slow Route to the Signaling Endosome , 2003, The Journal of Neuroscience.

[73]  C. Epstein,et al.  Synaptic structural abnormalities in the Ts65Dn mouse model of down syndrome , 2004, The Journal of comparative neurology.